President of Choice Packs Division
Mr. Wachler is the co-inventor of the Programmable Liquid Container for "Choice Enabling". He began his business career designing and selling custom jewelry. He then created a successful construction business in which he personally designs and builds unique waterfront homes. Mr. Wachler originated Ultimate Expression (TM) jeweled sculptures which meaningfully mark special occasions for "Modern Royalty". He writes essays and lectures on philosophy for which he is regularly featured on syndicated radio broadcasts.
Founder
Dr. Woolf founded IPIFINI in 2003 and also serves
on the Scientific Advisory Board of Signet Laboratories.
He founded and served as CEO of Sequitur, a biotechnology
company acquired by Invitrogen (Nasdaq: IVGN) in 2003. Dr.
Woolf holds a Masters and Doctorate in Biology from Harvard
University. He has authored 40 patents and scientific publications
and has given product development lectures throughout the
world. Products co-developed by Dr. Woolf have been used
in drug discovery efforts in most pharmaceutical companies
and have generated over $100 million in revenues. Dr. Woolf
invented a novel form of 2-dimensional DNA analysis while
at Cal Tech, invented the Beta-Safety Apron™ while
at Harvard University, co-invented therapeutic RNA editing,
Gene-blocks™ and lead therapeutic drugs at RPI (Nasdaq:
RNAI). He co-invented Version D™ antisense compounds,
Optimized Antisense™, Stealth RNAi™ and Ultramers™
at Sequitur.
VP
of Technology Development
Dr. Marks has a B.S. from Cornell University, a Ph.D. in
Cell and Molecular Biology from New York University School
of Medicine and a J.D. from Fordham Law School. In 2003
Dr. Marks left the practice of law to pursue technology
development full time. Dr. Marks spent ten years at the
intellectual property firm Fish & Neave in New York
as a patent agent and an associate. He also served as Chief
Patent Counsel at Vertex Pharmaceuticals (Nasdaq: VRTX),
a biopharmaceutical company in Cambridge, Massachusetts.
Dr. Marks has extensive experience in licensing, corporate
research & development partnerships and mergers and
acquisitions.
Licensing,
Pharmaceuticals and Consumer Products
Dr. Gill has over 20 years of technology commercialization
experience. He is currently CEO of Signet Laboratories.
Dr. Gill served as CEO of ActiveCyte, which provided an
enterprise wide solution for pharmaceutical intellectual
property licensing. He also served as President of the biotechnology
company Genome Therapeutics Corp. (Nasdaq: GENE). Prior
to this Dr. Gill served as Senior Vice President of BTG
(LSE: BGC), a global leader in the patenting and commercialization
of intellectual property rights. Earlier, he held research
and management positions at Unilever. Dr. Gill holds a Ph.D.
in Endocrinology and a BS in Physiology and Biochemistry.
Mechanical and
Electric Engineering & E-Commerce
Mr. Neumann earned his BS in Electrical Engineering with
a minor in Physics and Computer Science from Michigan State
University in 1980. He has led product development teams
of up to 150+ people in a variety of industrial settings.
While a Senior Engineer at Raytheon Corporation he played
a key role in hardening the Trident II missile guidance
system against nuclear electronic magnetic pulse. As a Program
Manager at the engineering firm Foster-Miller, he developed
innovative technology for Velcro, Frito-Lay, Warner-Lambert
and Becton Dickinson. More recently, he has focused on novel
e-commerce solutions, helping to raise more then $100 million
in venture and corporate financing for various start-up
companies.
Consumer
Products Marketing and Development
Mr. Goodwin has a 15 year marketing management career with
consumer product companies in the U.S. and abroad. He currently
serves as the Director, Global Business Development for
American Safety Razor where he is responsible for market
research and product development. Previously, he served
at Reckitt and Colman where he led the development and management
of the global $700 million surface care category (Chubbs,
Diaparene, Wet Ones, Lysol, Veja, Procenex, Pine-O-Cleen).
At Reckitt and Colman, Mr. Goodwin oversaw a $30 million
advertising budget and an eight person cross-functional
team comprised of marketing, research and development. He
led the development of Chubbs Stackable Baby Wipes and introduced
Lemon Scent Lysol Deodorizing Cleaner.
Software
Architect and Database Design
Mr. Anderson has over 20 years of software development experience,
and is an expert in process automation, user interfaces
and database design and implementation. David Anderson developed
business automation software for Electronic Data Systems,
General Motors, AT&T and numerous other institutions.
His expertise has been employed in the Healthcare, Telecom,
Financial and Utility sectors. He is currently the President
of NetBiz Systems, developing innovative building management
and cost accounting software.
